1
COVID-19 / Re: Efficacy - Comparing Like with Like
« on: 10/01/2021 14:22:47 »If one trial is testing the subject every week - then it will identify the asymptomatic infection; if another trial is only testing when symptoms develop then it will miss the asymptomatic infection and so give a different measure of efficacy?Both measured efficacy in the same way, the primary outcome - efficacy against symptomatic cases of covid-19 - which showed that the Oxford vaccine was 62.1% effective in participants who received two standard doses.
The Oxford trial also monitored for asymptomatic infections as a secondary outcome, which the Pfizer trial does not appear to have done.
The following users thanked this post: id2000